Clinical Trial Update: An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS [Phase 4]

View source ↗

Summary

Phase 4 head-to-head trial comparing two marketed therapies for relapsing-remitting multiple sclerosis has completed, assessing efficacy and safety. The documen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: COMPLETED